We also confirmed decreased m6A levels, as a consequence of Igf2bp3 deletion, from in vivo leukemia samples.13 Together, these results provide multiple orthogonal lines of evidence to show that the expression of IGF2BP3 results oncogenic metabolism and changes in RNA modifications. This evidence concerns the gene IGF2BP3 and leukemia.